Sodium/myo-inositol transporters: Substrate transport requirements and regional brain expression in the TgCRND8 mouse model of amyloid pathology

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Fenili, Daniela ^a   Weng, Ying Qi ^b   Aubert, Isabelle ^a,b   Nitz, Mark ^b   McLaurin, JoAnne ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CARRIER PROTEIN; INOSITOL; INOSITOL TRANSPORTER; SODIUM MYOINOSITOL TRANSPORTER 1; SODIUM MYOINOSITOL TRANSPORTER 2; UNCLASSIFIED DRUG; COTRANSPORTER; SLC5A3 PROTEIN, MOUSE; SMIT2 PROTEIN, MOUSE; SODIUM;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL ASSAY; CEREBELLUM; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STRAIN DIFFERENCE; ANIMAL; BRAIN; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

MUS;

AGING; ALZHEIMER DISEASE; AMYLOID; ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INOSITOL; MICE; MODELS, ANIMAL; SODIUM; SUBSTRATE SPECIFICITY; SYMPORTERS;

EID: 80052059432     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024032     Document Type: Article

References (29)

1. McLaurin J, Kierstead ME, Brown ME, Hawkes CA, Lambermon MH, et al. (2006) Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med 12: 801-808.
2. Fenili D, Brown M, Rappaport R, McLaurin J, (2007) Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology. J Mol Med 85: 603-611.
3. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, et al. (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276: 21562-21570.
4. Choi JK, Carreras I, Dedeoglu A, Jenkins BG, (2010) Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models. Neuropharmacology 59: 353-357.
5. Michaelis T, Helms G, Merboldt KD, Hänicke W, Bruhn H, et al. (1993) Identification of Scyllo-inositol in proton NMR spectra of human brain in vivo. N M R Biomed 6: 105-109.
6. Seaquist ER, Gruetter R, (1998) Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR. Magn Reson Med 39: 313-316.
7. Palmano KP, Whiting PH, Hawthorne JN, (1977) Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes. Biochem J 167: 229-235.
8. Kwon HM, Yamauchi A, Uchida S, Preston AS, Garcia-Perez A, et al. (1992) Cloning of the cDNa for a Na+/myo-inositol cotransporter, a hypertonicity stress protein. J Biol Chem 267: 6297-6301.
9. Hager K, Hazama A, Kwon HM, Loo DD, Handler JS, et al. (1995) Kinetics and specificity of the renal Na+/myo-inositol cotransporter expressed in Xenopus oocytes. J Membr Biol 143: 103-113.
10. Coady MJ, Wallendorff B, Gagnon DG, Lapointe JY, (2002) Identification of a novel Na+/myo-inositol cotransporter. J Biol Chem 277: 35219-35224.
11. Roll P, Massacrier A, Pereira S, Robaglia-Schlupp A, Cau P, et al. (2002) New human sodium/glucose cotransporter gene (KST1): identification, characterization, and mutation analysis in ICCA (infantile convulsions and choreoathetosis) and BFIC (benign familial infantile convulsions) families. Gene 285: 141-148.
12. Bourgeois F, Coady MJ, Lapointe JY, (2005) Determination of transport stoichiometry for two cation-coupled myo-inositol cotransporters: SMIT2 and HMIT. J Physiol 563: 333-343.
13. Berry GT, Mallee JJ, Kwon HM, Rim JS, Mulla WR, et al. (1995) The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. Genomics 25: 507-513.
14. Inoue K, Shimada S, Minami Y, Morimura H, Miyai A, et al. (1996) Cellular localization of Na+/MYO-inositol co-transporter mRNA in the rat brain. Neuroreport 7: 1195-1198.
15. Liu X, Erikson C, Brun A, (1996) Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. Dementia 7: 128-134.
16. Kaiser LG, Schuff N, Cashdollar N, Weiner MW, (2005) Scyllo-inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla. N M R Biomed 18: 51-55.
17. Wang VY, Zoghbi HY, (2001) Genetic regulation of cerebellar development. Nat Rev Neurosci 2: 484-491.
18. Thal DR, Rüb U, Orantes M, Braak H, (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58: 1791-1800.
19. Ostlund RE Jr, Seemayer R, Gupta S, Kimmel R, Ostlund EL, et al. (1996) A stereospecific myo-inositol/D-chiro-inositol transporter in HepG2 liver cells. Identification with D-chiro-[3-3H]inositol. J Biol Chem 271: 10073-10078.
20. Hakvoort A, Haselbach M, Galla HJ, (1998) Active transport properties of porcine choroid plexus cells in culture. Brain Res 795: 247-256.
21. Bissonnette P, Coady MJ, Lapointe JY, (2004) Expression of the sodium-myo-inositol cotransporter SMIT2 at the apical membrane of Madin-Darby canine kidney cells. J Physiol 558: 759-768.
22. Aouameur R, Da Cal S, Bissonnette P, Coady MJ, Lapointe JY, (2007) SMIT2 mediates all myo-inositol uptake in apical membranes of rat small intestine. Am J Physiol Gastrointest Liver Physiol 293: G1300-G1307.
23. Klaus F, Palmada M, Lindner R, Laufer J, Jeyaraj S, et al. (2008) Up-regulation of hypertonicity-activated myo-inositol transporter SMIT1 by the cell volume-sensitive protein kinase SGK1. J Physiol 586: 1539-1547.
24. Lin X, Ma L, Fitzgerald RL, Ostlund RE Jr, (2009) Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells. Arch Biochem Biophys 481: 197-201.
25. Rubin LJ, Hale CC, (1993) Characterization of a Mg-dependent, Na-inositol co-transport process in cardiac sarcolemmal vesicles. J Mol Cell Cardiol 25: 721-731.
26. Sun Y, Zhang G, Hawkes CA, Shaw JE, McLaurin J, et al. (2008) Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation. Bioorg Med Chem 16: 7177-7184.
27. Hawkes CA, Deng LH, Shaw JE, Nitz M, McLaurin J, (2010) Small molecule beta-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease. Eur J Neurosci 31: 203-213.
28. Transition Therapeutics Inc website. Available: http://www.transitiontherapeutics.com/media/archive.php. Accessed 2011 August 5.
29. Elan Corporation Website. Available: http://newsroom.elan.com/phoenix.zhtml?c=88326&p=irol-newsArticle&ID=1458241. Accessed 2011, August 5.